These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9346733)

  • 41. Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass.
    Arun J; Jhala N; Lazenby AJ; Clements R; Abrams GA
    Obes Surg; 2007 Feb; 17(2):155-61. PubMed ID: 17476865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients.
    Bahrami H; Daryani NE; Mirmomen S; Kamangar F; Haghpanah B; Djalili M
    BMC Gastroenterol; 2003 Oct; 3():27. PubMed ID: 14561231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recurrent familial hypobetalipoproteinemia-induced nonalcoholic fatty liver disease after living donor liver transplantation.
    Harada N; Soejima Y; Taketomi A; Yoshizumi T; Uchiyama H; Ikegami T; Saibara T; Nishizaki T; Maehara Y
    Liver Transpl; 2009 Jul; 15(7):806-9. PubMed ID: 19562718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome.
    Setji TL; Holland ND; Sanders LL; Pereira KC; Diehl AM; Brown AJ
    J Clin Endocrinol Metab; 2006 May; 91(5):1741-7. PubMed ID: 16492691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis.
    Hashimoto E; Taniai M; Kaneda H; Tokushige K; Hasegawa K; Okuda H; Shiratori K; Takasaki K
    Alcohol Clin Exp Res; 2004 Aug; 28(8 Suppl Proceedings):164S-168S. PubMed ID: 15318106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
    Ong J; Younossi ZM; Reddy V; Price LL; Gramlich T; Mayes J; Boparai N
    Liver Transpl; 2001 Sep; 7(9):797-801. PubMed ID: 11552214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Non alcoholic steatohepatitis].
    Manero E; Findor JA; Avagnina A; de Elizalde S; Elsner B
    Medicina (B Aires); 1994; 54(6):625-9. PubMed ID: 7658998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis.
    Uraz S; Aygun C; Sonsuz A; Ozbay G
    Dig Dis Sci; 2005 May; 50(5):964-9. PubMed ID: 15906776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.
    Seyam M; Neuberger JM; Gunson BK; Hübscher SG
    Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.
    Brunt EM; Janney CG; Di Bisceglie AM; Neuschwander-Tetri BA; Bacon BR
    Am J Gastroenterol; 1999 Sep; 94(9):2467-74. PubMed ID: 10484010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity.
    Stratopoulos C; Papakonstantinou A; Terzis I; Spiliadi C; Dimitriades G; Komesidou V; Kitsanta P; Argyrakos T; Hadjiyannakis E
    Obes Surg; 2005 Sep; 15(8):1154-60. PubMed ID: 16197789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis.
    Bhati C; Idowu MO; Sanyal AJ; Rivera M; Driscoll C; Stravitz RT; Kohli DR; Matherly S; Puri P; Gilles H; Cotterell A; Levy M; Sterling RK; Luketic VA; Lee H; Sharma A; Siddiqui MS
    Transplantation; 2017 Aug; 101(8):1867-1874. PubMed ID: 28296807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonalcoholic steatohepatitis.
    Sheth SG; Gordon FD; Chopra S
    Ann Intern Med; 1997 Jan; 126(2):137-45. PubMed ID: 9005748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.
    Vilar-Gomez E; Martinez-Perez Y; Calzadilla-Bertot L; Torres-Gonzalez A; Gra-Oramas B; Gonzalez-Fabian L; Friedman SL; Diago M; Romero-Gomez M
    Gastroenterology; 2015 Aug; 149(2):367-78.e5; quiz e14-5. PubMed ID: 25865049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonalcoholic steatohepatitis.
    Neuschwander-Tetri BA
    Clin Liver Dis; 1998 Feb; 2(1):149-73. PubMed ID: 15560051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Non-alcoholic liver disease (NASH)].
    Maier KP
    Praxis (Bern 1994); 2006 Aug; 95(34):1267-9. PubMed ID: 16956020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis.
    Amarapurka DN; Amarapurkar AD; Patel ND; Agal S; Baigal R; Gupte P; Pramanik S
    Ann Hepatol; 2006; 5(1):30-3. PubMed ID: 16531962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
    Harrison SA; Torgerson S; Hayashi PH
    Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pathology of nonalcoholic steatohepatitis].
    Jeen YM; Jin SY
    Korean J Hepatol; 2009 Jun; 15(2):122-30. PubMed ID: 19581764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Nonalcoholic steatohepatitis, the enigma of bad progression].
    López Diéguez Puerta M; Casal Esteban V; Barbado Hernández FJ; Gil Guerrero L; Rodríguez Molinero MA; Larrauri J; Vázquez Rodríguez JJ
    An Med Interna; 2005 Feb; 22(2):85-7. PubMed ID: 15898887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.